When: 2pm ET (11am PT), 29 January 2025
Where: Online (register here)
Douglas CDMO will present at the Outsourced Pharma Capacity Update Partner Week 2025.
You are invited to hear from Chief Scientific Officer Peter Surman and Head of Delivery Lora Wallis as part of the Small Molecule Session on Wednesday 29 January 2pm ET (11am PT).
With extensive experience in developing and manufacturing a variety of dosage forms, and deep specialist expertise in high-potency softgel and liquid formulations, Douglas CDMO brings world-class knowledge and reputable high-quality standards to the table. We look forward to demonstrating our capabilities and fielding your questions on how we can support your product development.
For more information or to register for this event, please see the event website.
Peter Surman, Chief Scientific Officer
Lora Wallis, Head of Delivery – Pharma
Register for Outsourced Pharma Capacity Update Partner Week: Small Molecule Session
RegisterOther posts you may be interested in...
Articles
Bespoke client solutions: A personalized approach as a privately owned CDMO
Douglas CDMO is making its mark in the pharmaceutical development industry with their flexible and personalized approaches to client needs.
Learn MoreArticles
Smart softgels: driving innovation in pharma
In the dynamic landscape of pharmaceuticals, one innovation has consistently pushed the boundaries of drug delivery: the softgel capsule.
Learn MoreCase Studies
Seizing market share pre-patent expiry: Navigating a paragraph IV ANDA submission
Douglas CDMO partnered with a US pharmaceutical firm to develop a cutting-edge generic isotretinoin softgel, overcoming regulatory and technical complexities, launching with remarkable success.
Learn More